Skip to main content
. Author manuscript; available in PMC: 2015 May 19.
Published in final edited form as: Gynecol Oncol. 2009 Oct 12;116(1):78–81. doi: 10.1016/j.ygyno.2009.09.027

Fig. 1.

Fig. 1

Effect of LDL levels on progression-free survival. Median progression-free survival was statistically longer in patients with normal LDL (27 months), compared to those with elevated LDL (12 months, p = 0.0004).